Medical Equipment

Global Neurovascular Embolization Devices Market 2026–2030: Forecast Insights for Business Planning

February 9, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Neurovascular Embolization Devices Market be in 2030 compared with 2026?

The market size for neurovascular embolization devices has shown robust expansion in recent years. This market is forecast to increase from $1.38 billion in 2025 to $1.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The growth observed in prior periods can be attributed to the rising incidence of cerebral aneurysms, the expanding scope of neurointerventional procedures, an increasing number of skilled neurovascular specialists, growing hospital investments in advanced neurocare, and the wider adoption of minimally invasive stroke treatments.

The neurovascular embolization devices market is anticipated to experience robust growth over the coming years, with projections indicating it will expand to $1.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This growth throughout the forecast period is primarily driven by a surging demand for advanced stroke management solutions, escalating investments in neurovascular research and development, the expanding elderly demographic affected by vascular disorders, increasing adoption rates of next-generation embolization devices, and a heightened focus on enhancing procedural outcomes. Key trends characterizing this period are expected to include the rising uptake of flow diversion stents, a greater deployment of liquid embolic systems, an evolving preference for minimally invasive neurointerventions, the proliferation of coil technologies featuring advanced coatings, and an intensified emphasis on precision neurovascular devices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp

What Drivers Are Guiding Growth Patterns In The Neurovascular Embolization Devices Market?

The growing incidence of hemorrhages is anticipated to propel the neurovascular embolization devices market in the coming years. Hemorrhages are characterized as unusual and uncontrolled bleeding that occurs either internally within the body or externally through a break in the skin or mucous membrane. The increasing occurrence of hemorrhages is linked to several factors, including an aging demographic, a heightened prevalence of hypertension, and the expanded application of anticoagulant medications. Neurovascular embolization devices are employed in hemorrhagic strokes to block abnormal blood vessels, thereby reducing bleeding and preventing additional damage to the brain. For instance, in February 2024, research from King’s College London, a UK-based public research university, indicated that the number of cases and deaths from intracerebral hemorrhage (ICH), a specific form of hemorrhage, is projected to rise by 59.4% in people aged 70 to 95 across the UK by 2050. Consequently, the rising prevalence of hemorrhages drives the growth of the neurovascular embolization devices market.

Which Segments Are Driving Activity In The Neurovascular Embolization Devices Market?

The neurovascular embolization devices market covered in this report is segmented –

1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products

2) By Treatment: Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions

3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications

4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings

2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System

3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment

4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips

5) By Other Products: Balloons For Embolization, Microcatheters

Which Trends Are Influencing The Performance And Direction Of The Neurovascular Embolization Devices Market?

Leading firms within the neurovascular embolization devices market are prioritizing the creation of sophisticated alternatives, including advanced flow diverters, to supersede conventional approaches for aneurysm management. Such a next-generation flow diverter is defined as an instrument designed to boost procedural safety and effectiveness through better vessel wall conformity, diminished risk of clot formation, and simplified placement in intricate aneurysm structures. An illustration of this progress is seen in July 2025, when Stryker Corporation, a US-based medical technology company, introduced the Surpass Elite Flow Diverter to its collection of neurovascular offerings. This novel product is engineered to substitute previous generation aneurysm treatment tools, delivering a minimally invasive flow diversion solution for substantial or exceptionally large unruptured intracranial aneurysms. It offers enhanced resistance to thrombus formation and a refined braid configuration, enabling medical professionals to secure superior procedural results with reduced handling. Its integration with Stryker’s comprehensive training and physician support initiatives ensures a smooth clinical application. Ultimately, the Surpass Elite Flow Diverter elevates patient safety, streamlines the procedural process, and contributes to broader acceptance of flow diversion therapy within neurovascular treatment.

Which Key Players Are Driving Competition In The Neurovascular Embolization Devices Market?

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Neurovascular Embolization Devices Market?

North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Neurovascular Embolization Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15871&type=smp

Browse Through More Reports Similar to the Global Neurovascular Embolization Devices Market 2026, By The Business Research Company

Tumor Embolization Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Transcatheter Embolization And Occlusion Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report

Vascular Embolization Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795